Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.

1995103 citationsJournal Article

Authors

Gunnar Juliusson · Hospital IT

Dag Heldal

Abstract

Subcutaneous injection of CdA is safe and as effective as continuous infusion without problems associated with the mode of administration. Our schedule simplifies CdA treatment and can be generally recommended.

Topics & Keywords

Chronic Lymphocytic Leukemia Research Immunodeficiency and Autoimmune Disorders Lymphoma Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 13, Issue 4, pp. 989-995

DOI: 10.1200/jco.1995.13.4.989

Field-Weighted Citation Impact: 7.20